Advanced search
Publication Cover
Acta Oncologica Volume 53, 2014 - Issue 1
Journal homepage
1,980
Views
42
CrossRef citations to date
0
Altmetric
Urologic oncology

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib – a multicentric retrospective analysis

Benoit BeuselinckDepartment of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium;Inserm U674 Génomique fonctionnelle des tumeurs solides, Université Paris-5 René Descartes, Paris, FranceCorrespondence[email protected]
,
Alexandra KaradimouInserm U674 Génomique fonctionnelle des tumeurs solides, Université Paris-5 René Descartes, Paris, France
,
Diether LambrechtsLaboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium;Vesalius Research Center, VIB, Leuven, Belgium
,
Bart ClaesLaboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium;Vesalius Research Center, VIB, Leuven, Belgium
,
Pascal WolterDepartment of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
,
Gabrielle CouchyInserm U674 Génomique fonctionnelle des tumeurs solides, Université Paris-5 René Descartes, Paris, France
,
Joost BerkersDepartment of Urology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
,
Hendrik van PoppelDepartment of Urology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
,
Robert ParidaensDepartment of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
,
Patrick SchöffskiDepartment of General Medical Oncology and Laboratory for Experimental Oncology, University Hospitals Leuven, Leuven Cancer Institute, KU Leuven, Leuven, Belgium
,
Arnaud MéjeanDepartment of Urology, Georges Pompidou European Hospital, Université Paris-5 René Descartes, Paris, France
,
Virginie VerkarreDepartment of Pathology, Hôpital Necker-Enfants malades, Université Paris-5 René Descartes, Paris, France
,
Evelyne LerutDepartment of Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
,
Florence JolyDepartment of Medical Oncology, Centre François Baclesse, Caen, France
,
Thierry LebretDepartment of Urology, Hôpital Foch, Suresnes, France
,
Gwénaelle GravisDepartment of Medical Oncology, Institut Paoli-Calmettes, Marseille, France
,
Gael DeplanqueDepartment of Medical Oncology, Clinique St-Joseph, Paris, France
,
Aurélien DescazeaudDepartment of Urology, Hôpital Dupuytren, Limoges, France
,
Nathalie Rioux LeclercqDepartment of Pathology, CHU Rennes, Rennes, France
,
Vincent MoliniéDepartment of Pathology, Clinique St-Joseph, Paris, France
,
Jean-Jacques PatardDepartment of Urology, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
,
Corine TeghomDepartment of Medical Oncology, Georges Pompidou European Hospital, Université Paris-5 René Descartes, Paris, France
,
Reza ElaidiDepartment of Medical Oncology, Georges Pompidou European Hospital, Université Paris-5 René Descartes, Paris, France
,
Jessica Zucman-RossiInserm U674 Génomique fonctionnelle des tumeurs solides, Université Paris-5 René Descartes, Paris, France;Department of Medical Oncology, Georges Pompidou European Hospital, Université Paris-5 René Descartes, Paris, France
&
Stéphane OudardInserm U674 Génomique fonctionnelle des tumeurs solides, Université Paris-5 René Descartes, Paris, France;Department of Medical Oncology, Georges Pompidou European Hospital, Université Paris-5 René Descartes, Paris, France
 show all
Pages 103-112 | Received 22 Oct 2012, Accepted 19 Jan 2013, Published online: 20 Feb 2013

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Emilie Werbrouck, Julie Bastin, Diether Lambrechts, Annelies Verbiest, Thomas Van Brussel, Evelyne Lerut, Jean-Pascal Machiels, Vincent Verschaeve, Vincent Richard, Philip R. Debruyne, Brigitte Decallonne, Patrick Schöffski, Oliver Bechter, Pascal Wolter & Benoit Beuselinck. (2019) ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib. Acta Clinica Belgica 74:3, pages 180-188.
Read now
Bengt Glimelius. (2016) Tell all the good news as soon as possible. Acta Oncologica 55:9-10, pages 1067-1068.
Read now
Meta H. M. Diekstra, Jesse J. Swen, Hans Gelderblom & Henk-Jan Guchelaar. (2016) A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review. Expert Review of Molecular Diagnostics 16:5, pages 605-618.
Read now
Jason Yongsheng Chan, Yukti Choudhury & Min-Han Tan. (2015) Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges. Expert Review of Molecular Diagnostics 15:5, pages 631-646.
Read now
Benoit Beuselinck, Diether Lambrechts, Thomas Van Brussel, Pascal Wolter, Nina Cardinaels, Steven Joniau, Evelyne Lerut, Alexandra Karadimou, Gabrielle Couchy, Philippe Sebe, Alain Ravaud, Marc Zerbib, Armelle Caty, Robert Paridaens, Patrick Schöffski, Virginie Verkarre, Julien Berger, Jean-Jacques Patard, Jessica Zucman-Rossi & Stéphane Oudard. (2014) Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib. Acta Oncologica 53:10, pages 1413-1422.
Read now
Yann-Alexandre Vano, Eric Tartour, Laure S Fournier, Benoit Beuselinck, Arnaud Mejean & Stephane Oudard. (2014) Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents. Expert Review of Anticancer Therapy 14:5, pages 523-542.
Read now

Articles from other publishers (36)

Zoé Guillaume, Marie Auvray, Yann Vano, Stéphane Oudard, Dominique Helley & Laetitia Mauge. (2022) Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies. Cancers 14:24, pages 6167.
Crossref
David Blánquez-Martínez, Xando Díaz-Villamarín, Sonia García-Rodríguez, Alba Antúnez-Rodríguez, Ana Pozo-Agundo, Luis Javier Martínez-González, José Ignacio Muñoz-Ávila & Cristina Lucía Dávila-Fajardo. (2022) Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients. Pharmaceutics 14:8, pages 1555.
Crossref
Meta H. M. Diekstra, Jesse J. Swen, Loes F. M. van der Zanden, Sita H. Vermeulen, Epie Boven, Ron H. J. Mathijssen, Koya Fukunaga, Taisei Mushiroda, Fumiya Hongo, Egbert Oosterwijk, Anne Cambon-Thomsen, Daniel Castellano, Achim Fritsch, Jesus Garcia Donas, Cristina Rodriguez-Antona, Rob Ruijtenbeek, Marius T. Radu, Tim Eisen, Kerstin Junker, Max Roessler, Ulrich Jaehde, Tsuneharu Miki, Stefan Böhringer, Michiaki Kubo, Lambertus A. L. M. Kiemeney & Henk-Jan Guchelaar. (2022) Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib. Cancers 14:12, pages 2838.
Crossref
Domenico Ribatti, Antonio Giovanni Solimando & Francesco Pezzella. (2021) The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers 13:14, pages 3433.
Crossref
Sophia Frentzas, Caroline Lum & Ting-Yu Chen. 2020. Current Cancer Treatment. Current Cancer Treatment.
Nicola Fazio, Jean-Francois Martini, Adina E Croitoru, Michael Schenker, Sherry Li, Brad Rosbrook, Kathrine Fernandez, Jiri Tomasek, Espen Thiis-Evensen, Matthew Kulke & Eric Raymond. (2019) Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors. Future Oncology 15:17, pages 1997-2007.
Crossref
Daniel J. George, Jean-Francois Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, Sherry Li, Michelle Casey, Olga Valota, Brigitte Laguerre, Allan J. Pantuck, Hardev S. Pandha, Anup Patel, Maria Lechuga & Alain Ravaud. (2019) Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis. Clinical Cancer Research 25:4, pages 1165-1173.
Crossref
David D. Stenehjem, Andrew W. Hahn, David M. Gill, Daniel Albertson, Banumathy Gowrishankar, Joseph Merriman, Archana M. Agarwal, Venkata Thodima, Erik B. Harrington, Trang H. Au, Benjamin L. Maughan, Jane Houldsworth, Sumanta K. Pal & Neeraj Agarwal. (2019) Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. PLOS ONE 14:1, pages e0210415.
Crossref
Weibin Hou & Stefan Duensing. 2019. Tumor Angiogenesis. Tumor Angiogenesis 293 310 .
Cristina Suárez, Marc Campayo, Romà Bastús, Sergi Castillo, Olatz Etxanitz, Marta Guix, Núria Sala & Enrique Gallardo. (2018) Prognostic and Predictive Factors for Renal Cell Carcinoma. Targeted Oncology 13:3, pages 309-331.
Crossref
Matteo Morotti, Prashanth Hari Dass, Adrian L. Harris & Simon Lord. (2017) Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients. European Journal of Drug Metabolism and Pharmacokinetics 43:2, pages 137-153.
Crossref
J S L Kloth, M C Verboom, J J Swen, T van der Straaten, S Sleijfer, A K L Reyners, N Steeghs, H Gelderblom, H J Guchelaar & R H J Mathijssen. (2017) Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinib. The Pharmacogenomics Journal 18:1, pages 49-55.
Crossref
David M. Gill, Andrew W. Hahn, Peter Hale & Benjamin L. Maughan. (2018) Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma. Current Treatment Options in Oncology 19:1.
Crossref
Chenkui Miao, Jingyi Cao, Yuhao Wang, Bianjiang Liu & Zengjun Wang. (2017) Effects of VEGF and VEGFR polymorphisms on the outcome of patients with metastatic renal cell carcinoma treated with sunitinib: a systematic review and meta-analysis. Oncotarget 8:40, pages 68854-68862.
Crossref
Xiaoyan Liu, Jesse J. Swen, Epie Boven, Daniel Castellano, Hans Gelderblom, Ron H.J. Mathijssen, Cristina Rodríguez-Antona, Jesus García-Donas, Brian I. Rini & Henk-Jan Guchelaar. (2016) Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients . Oncotarget 8:1, pages 1204-1212.
Crossref
Weibin Hou & Stefan Duensing. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 18 .
Solomon L. Woldu & Vitaly Margulis. (2016) Single nucleotide polymorphisms of the vascular endothelial growth factor receptor - a promising biomarker in metastatic renal cell carcinoma. BJU International 118:6, pages 847-848.
Crossref
Benoit Beuselinck, Johnny Jean-Baptiste, Patrick Schöffski, Gabrielle Couchy, Clément Meiller, Frederic Rolland, Yves Allory, Steven Joniau, Virginie Verkarre, Reza Elaidi, Evelyne Lerut, Tania Roskams, Jean-Jacques Patard, Stephane Oudard, Arnaud Méjean, Diether Lambrechts & Jessica Zucman-Rossi. (2016) Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib. BJU International 118:6, pages 890-901.
Crossref
Juana Dornbusch, Martina Walter, Andrea Gottschalk, Alice Obaje, Kerstin Junker, Carsten-Henning Ohlmann, Matthias Meinhardt, Aristeidis Zacharis, Stefan Zastrow, Olaf Schoffer, Marc-Oliver Grimm, Stefanie J. Klug, Manfred P. Wirth & Susanne Fuessel. (2016) Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients. Journal of Cancer Research and Clinical Oncology 142:6, pages 1171-1182.
Crossref
Siew-Kee Low, Koya Fukunaga, Atsushi Takahashi, Koichi Matsuda, Fumiya Hongo, Hiroyuki Nakanishi, Hiroshi Kitamura, Takamitsu Inoue, Yoichiro Kato, Yoshihiko Tomita, Satoshi Fukasawa, Tomoaki Tanaka, Kazuo Nishimura, Hirotsugu Uemura, Isao Hara, Masato Fujisawa, Hideyasu Matsuyama, Katsuyoshi Hashine, Katsunori Tatsugami, Hideki Enokida, Michiaki Kubo, Tsuneharu Miki & Taisei Mushiroda. (2016) Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction. PLOS ONE 11:2, pages e0148177.
Crossref
Seyed Mohammad Hossein Kashfi, Faegheh Behboudi Farahbakhsh, Ehsan Nazemalhosseini Mojarad, Kazem Mashayekhi, Pedram Azimzadeh, Sara Romani, Shaghayegh Derakhshani, Habib Malekpour, Hamid Asadzadeh Aghdaei & Mohammad Reza Zali. (2015) Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer. Tumor Biology 37:2, pages 2119-2126.
Crossref
Shuang Xie, Feng Zhou, Jiaojiao Wang, Haiyan Cao, Yibing Chen, Xiaonan Liu, Zhaohui Zhang, Jingyao Dai & Xianli He. (2015) Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer. World Journal of Surgical Oncology 13:1.
Crossref
Meta H. M. Diekstra, Xiaoyan Liu, Jesse J. Swen, Epie Boven, Daniel Castellano, Hans Gelderblom, Ron H. J. Mathijssen, Cristina Rodríguez-Antona, Jesus García-Donas, Brian I. Rini & Henk-Jan Guchelaar. (2015) Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma. European Journal of Clinical Pharmacology 71:12, pages 1477-1484.
Crossref
Ying-Hsia Chu, Huihua Li, Hui Shan Tan, Valerie Koh, Johnathan Lai, Wai Min Phyo, Yukti Choudhury, Ravindran Kanesvaran, Noan Minh Chau, Chee Keong Toh, Quan Sing Ng, Puay Hoon Tan, Balram Chowbay & Min-Han Tan. (2015) Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma. PLOS ONE 10:8, pages e0134102.
Crossref
Benoit Beuselinck & Jessica Zucman-Rossi. (2015) Single nucleotide polymorphisms in mRCC—is their time up?. Nature Reviews Urology 12:8, pages 424-426.
Crossref
Bernard Escudier, Brian I. Rini, Robert J. Motzer, Jamal Tarazi, Sinil Kim, Xin Huang, Brad Rosbrook, Patricia A. English, A. Katrina Loomis & J. Andrew Williams. (2015) Genotype Correlations With Blood Pressure and Efficacy From a Randomized Phase III Trial of Second-Line Axitinib Versus Sorafenib in Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 13:4, pages 328-337.e3.
Crossref
Dylan M. Glubb, Laia Paré-Brunet, Eloisa Jantus-Lewintre, Chen Jiang, Daniel Crona, Amy S. Etheridge, Osman Mirza, Wei Zhang, Eric L. Seiser, Witold Rzyman, Jacek Jassem, Todd Auman, Fred R. Hirsch, Kouros Owzar, Carlos Camps, Rafal Dziadziuszko & Federico Innocenti. (2015) Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I–III Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology 10:7, pages 1067-1075.
Crossref
Jesus Garcia-Donas, Juan Francisco Rodriguez-Moreno, Nuria Romero-Laorden & Cristina Rodriguez-Antona. (2015) Renal carcinoma pharmacogenomics and predictors of response: Steps toward treatment individualization. Urologic Oncology: Seminars and Original Investigations 33:4, pages 179-186.
Crossref
Daniele Minardi, Luigi Quaresima, Matteo Santoni, Maristella Bianconi, Mario Scartozzi, Stefano Cascinu & Giovanni Muzzonigro. (2015) Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature. Current Urology Reports 16:2.
Crossref
S.C. Joosten, L. Hamming, P.M. Soetekouw, M.J. Aarts, J. Veeck, M. van Engeland & V.C. Tjan-Heijnen. (2015) Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:1, pages 1-16.
Crossref
Johannes C. van der Mijn, James W. Mier, Henk J. Broxterman & Henk M. Verheul. (2014) Predictive biomarkers in renal cell cancer: Insights in drug resistance mechanisms. Drug Resistance Updates 17:4-6, pages 77-88.
Crossref
H. Wang, L. Yang, J. Deng, B. Wang, X. Yang, R. Yang, M. Cheng, W. Fang, F. Qiu, X. Zhang, W. Ji, P. Ran, Y. Zhou & J. Lu. (2014) Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population. Mutagenesis 29:5, pages 311-317.
Crossref
Naveen S. Vasudev & Andrew R. Reynolds. (2014) Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis 17:3, pages 471-494.
Crossref
Sumanta K. Pal & Robert A. Figlin. (2014) Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?. Cancer 120:11, pages 1604-1607.
Crossref
Y Wang, T K Choueiri, J-L Lee, M-H Tan, S Y Rha, S A North, C K Kollmannsberger, D F McDermott & D Y C Heng. (2014) Anti-VEGF therapy in mRCC: differences between Asian and non-Asian patients. British Journal of Cancer 110:6, pages 1433-1437.
Crossref
Rosalie Fisher & James Larkin. (2013) Individualising treatment choices in a crowded treatment algorithm. European Journal of Cancer Supplements 11:2, pages 160-168.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.